Geode Capital Management, LLC Y M Abs Therapeutics, Inc. Transaction History

Geode Capital Management, LLC

$1.07 Trillion
Q1 2024

A detailed history of Geode Capital Management, LLC transactions in Y M Abs Therapeutics, Inc. stock. As of the latest transaction made, Geode Capital Management, LLC holds 742,749 shares of YMAB stock, worth $8.61 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

742,749

Previous 738,548 0.57%

Holding current value

$8.61 Million

Previous $5.04 Million 139.81%

% of portfolio

0.0%

Previous 0.0%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$6.57 - $18.69 $27,600 - $78,516	4,201 Added 0.57%	742,749 $12.1 Million
Q4 2023 Feb 13, 2024	BUY	$4.88 - $7.42 $135,249 - $205,645	27,715 Added 3.9%	738,548 $5.04 Million
Q3 2023 Nov 13, 2023	SELL	$4.86 - $7.23 $4,038 - $6,008	-831 Reduced 0.12%	710,833 $3.87 Million
Q2 2023 Aug 11, 2023	BUY	$5.68 - $10.34 $278,427 - $506,856	49,019 Added 7.4%	711,664 $4.83 Million
Q1 2023 May 15, 2023	BUY	$2.83 - $5.11 $88,723 - $160,203	31,351 Added 4.97%	662,645 $3.32 Million

Q4 2022 Feb 13, 2023	SELL	$3.0 - $15.17 $4,803 - $24,287	-1,601 Reduced 0.25%	631,294 $3.08 Million
Q3 2022 Nov 14, 2022	BUY	$13.96 - $19.67 $93,908 - $132,320	6,727 Added 1.07%	632,895 $9.13 Million
Q2 2022 Aug 12, 2022	BUY	$8.22 - $15.13 $350,492 - $645,128	42,639 Added 7.31%	626,168 $9.47 Million
Q1 2022 May 13, 2022	SELL	$6.55 - $17.42 $245,284 - $652,344	-37,448 Reduced 6.03%	583,529 $6.93 Million
Q4 2021 Feb 11, 2022	BUY	$15.51 - $29.31 $680,361 - $1.29 Million	43,866 Added 7.6%	620,977 $10.1 Million
Q3 2021 Nov 12, 2021	BUY	$27.47 - $37.31 $715,978 - $972,447	26,064 Added 4.73%	577,111 $16.5 Million
Q2 2021 Aug 13, 2021	BUY	$25.45 - $37.64 $1.96 Million - $2.9 Million	76,929 Added 16.23%	551,047 $18.6 Million
Q1 2021 May 12, 2021	BUY	$29.16 - $51.96 $1.26 Million - $2.25 Million	43,240 Added 10.04%	474,118 $14.3 Million
Q4 2020 Feb 12, 2021	BUY	$37.86 - $54.26 $1.12 Million - $1.61 Million	29,701 Added 7.4%	430,878 $21.3 Million
Q3 2020 Nov 13, 2020	BUY	$35.13 - $43.62 $1.5 Million - $1.86 Million	42,614 Added 11.88%	401,177 $15.4 Million
Q2 2020 Aug 13, 2020	BUY	$23.66 - $49.53 $1.21 Million - $2.54 Million	51,241 Added 16.67%	358,563 $15.5 Million
Q1 2020 May 14, 2020	BUY	$14.39 - $35.8 $505,146 - $1.26 Million	35,104 Added 12.9%	307,322 $8.02 Million
Q4 2019 Feb 13, 2020	BUY	$23.81 - $33.78 $1.62 Million - $2.3 Million	68,016 Added 33.31%	272,218 $8.51 Million
Q3 2019 Nov 12, 2019	BUY	$21.57 - $31.37 $846,040 - $1.23 Million	39,223 Added 23.77%	204,202 $5.32 Million
Q2 2019 Aug 14, 2019	BUY	$19.51 - $28.31 $1.47 Million - $2.14 Million	75,509 Added 84.4%	164,979 $3.77 Million
Q1 2019 May 14, 2019	BUY	$18.21 - $26.21 $208,285 - $299,789	11,438 Added 14.66%	89,470 $2.35 Million
Q4 2018 Feb 13, 2019	BUY	$15.41 - $28.92 $1.2 Million - $2.26 Million	78,032 New	78,032 $1.59 Million

Others Institutions Holding YMAB

# of Institutions

Shares Held

22.4M

Call Options Held

37.4K

Put Options Held

48.2K

View Full List

About Y-mAbs Therapeutics, Inc.

Ticker YMAB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,719,500
Market Cap $507M
Description
Y-mAbs Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of novel antibody based therapeutic products for the treatment of cancer in the United States. It offers DANYELZA, a monoclonal antibody in combination with granulocyte-macrophage colony-stimulating factor for the treatment o...

More about YMAB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.

Account

Geode Capital Management, LLC Y M Abs Therapeutics, Inc. Transaction History